AzTrials
AzTrials

Post Traumatic Stress SymptomsEMDR-IGTP-OTSNCT07027930

A Feasibility Trial of Eye Movement Desensitization and Reprocessing Therapy- Integrative Treatment Group Protocol for Ongoing Traumatic Stress In Road Traffic Accident Survivors for Reduction of Post-traumatic Stress Symptoms

A study testing Eye movement desensitization and reprocessing therapy integrative group treatment protocol for Ongoing traumatic stress in people with Post Traumatic Stress Symptoms and Quality of Life (QOL), run by University of the Punjab at 1 site in Pakistan.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Road traffic accidents (RTAs) are a significant public health concern globally, accounting for a substantial proportion of morbidity and mortality. This study evaluates the feasibility and acceptability of the Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol for Ongoing Traumatic… Read more about this study

Who is it for?
Ages 18 to 45 years
What is being tested?
Eye movement desensitization and reprocessing therapy integrative group treatment protocol for Ongoing traumatic stress
Could I receive a placebo?
No, everyone receives an active treatment
How many people
35 participants
Where
1 sitePakistan
Study dates
1 May 2025to 1 Nov 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Aged between 18 and 45 years.
  • Experienced a traffic accident 3 months to 10 years prior
  • Willing to participate and able to understand the intervention components.

Who cannot join

  • Participants will be excluded from the study if they meet any of the following criteria:
  • Diagnosed with conditions such as schizophrenia or bipolar disorder, which require specialized treatment beyond the scope of this study.
  • History of severe head injuries resulting in neurological or cognitive deficits.
  • Participants who have experienced a traffic accident less than 3 months ago, as immediate post-traumatic responses may not have stabilized

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Khawer Javed, MS clinical Psychology contact

+92 3415014715

khwr348@gmail.com

Dr Nazia Bashir, Phd Clinical Psychology contact

+92 321 4427751

nazia.ccpsy@pu.edu.pk

Pakistan1 site, 1 recruiting
  • Public Universities

    Lahore, Punjab Province, 54000

    Recruiting

Other trials in Pakistan

About this study

Official title: A Feasibility Trial of Eye Movement Desensitization and Reprocessing Therapy- Integrative Treatment Group Protocol for Ongoing Traumatic Stress in Road Traffic Accident Survivors for Reduction of Post-Traumatic Stress Symptoms

Road traffic accidents (RTAs) are a significant public health concern globally, accounting for a substantial proportion of morbidity and mortality. This study evaluates the feasibility and acceptability of the Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol for Ongoing Traumatic Stress (EMDR-IGTP-OTS) in the reduction of posttraumatic stress symptoms, depression, and anxiety, while improving the quality of life in individuals who have experienced traffic accidents. Using a randomized control design, participants aged 18-45 will be assessed at three-time points: pre-treatment, post-treatment, and one-month follow-up. The study employs the DASS-21, UIES-R, and WHOQOL-BREF as evaluation measures. Findings aim to expand evidence on trauma-focused interventions and explore their applicability in culturally diverse, resource-constrained settings.

Being tested
Eye movement desensitization and reprocessing therapy integrative group treatment protocol for Ongoing traumatic stress

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Eye movement desensitization and reprocessing therapy integrative group treatment protocol for Ongoing traumatic stressOther

    EMDR-IGTP-OTS is a group intervention based on EMDR 8-phased protocols with the integration of the Butterfly hug technique.

Study groups in NCT07027930
Study groupRoleWhat they receive
EMDR-IGTP-OTSExperimentalEye movement desensitization and reprocessing therapy for ongoing traumatic stress
Receives: Other: Eye movement desensitization and reprocessing therapy integrative group treatment protocol for Ongoing traumatic stress
Comparison ArmNo interventionThis would be used as a control arm

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Urdu Impact of Event Scale-Revised

    It will measure trauma-specific symptoms such as intrusion, avoidance, and hyperarousal. This 22-item scale uses a 5-point Likert scale ranging from 0 (not at all) to 4 (extreme), comprehensively evaluating the psychological impact of traumatic incidents. Higher the scores, Higher will be severity of post traumatic symptoms.

    Measured: From Enrollment to end of study after 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Jun 2025
  2. Study start1 May 2025
  3. Primary completion25 Sep 2025 (estimated)
  4. Study completion1 Nov 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
35 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07027930
Sponsor's protocol ID
IGTP-OTS-MSCCP-2022
Acronym
EMDR-IGTP-OTS
Status last verified
Jun 2025
First submitted
30 May 2025
Last updated
19 Jun 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual Participant Data (IPD) will not be shared due to concerns regarding participant confidentiality, especially given the sensitive nature of trauma-related experiences addressed in the study. Although anonymization procedures are in place, the qualitative nature of the data and small sample size may still pose a risk of indirect identification. Therefore, to uphold ethical standards and protect participant privacy, we have decided not to share IPD publicly

Publications

  • Yasar AB, Konuk E, Kavakci O, Uygun E, Gundogmus I, Taygar AS, Uludag E. A Randomized-Controlled Trial of EMDR Flash Technique on Traumatic Symptoms, Depression, Anxiety, Stress, and Life of Quality With Individuals Who Have Experienced a Traffic Accident. Front Psychol. 2022 Mar 24;13:845481. doi: 10.3389/fpsyg.2022.845481. eCollection 2022.

    PubMed 35401305

Questions about this trial

What is this clinical trial studying?

A study testing Eye movement desensitization and reprocessing therapy integrative group treatment protocol for Ongoing traumatic stress in people with Post Traumatic Stress Symptoms and Quality of Life (QOL), run by University of the Punjab at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 19 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Khawer Javed, MS clinical Psychology (+92 3415014715, khwr348@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Urdu Impact of Event Scale-Revised (time frame: From Enrollment to end of study after 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07027930, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in